充血性心力衰竭PPT课件.ppt

充血性心力衰竭PPT课件.ppt

ID:208259

大小:406.50 KB

页数:30页

时间:2017-07-03

充血性心力衰竭PPT课件.ppt_第1页
充血性心力衰竭PPT课件.ppt_第2页
充血性心力衰竭PPT课件.ppt_第3页
充血性心力衰竭PPT课件.ppt_第4页
充血性心力衰竭PPT课件.ppt_第5页
资源描述:

《充血性心力衰竭PPT课件.ppt》由会员上传分享,免费在线阅读,更多相关内容在教育资源-天天文库

1、CongestiveHeartFailureCollaborative,October14,2004PreventingReadmissionsKennethA.LaBresh,MD,FAHA,FACCV.P.,MedicalAffairsandQualityImprovement,MassPROClinicalAssociateProfessor,BrownUniversityACC/AHAGuidelinesforEvaluationandManagementofChronicHeartFailure2001HFcanbepreve

2、ntedHFhasestablishedriskfactorsHFisaprogressiveconditionwithasymptomaticandsymptomaticstagesHFmorbidityandmortalitycanbereducedbystagespecifictreatmentsHunt,etal.JAmCollCardiol.2001;38:2101-2113.ACC/AHAProposedStagesofHFSTAGEAHighriskfordevelopingHFSTAGEBAsymptomaticLVdy

3、sfunctionSTAGECPastorcurrentsymptomsofHFSTAGEDEnd-stageHFHunt,etal.JAmCollCardiol.2001;38:2101-2113.NeurohormonalActivationin HeartFailureHypertrophy,apoptosis,ischemia,arrhythmias,remodeling,fibrosisAngiotensinIINorepinephrineMorbidityandMortalityCNSsympatheticoutflow

4、CardiacsympatheticactivityRenalsympatheticactivitySodiumretentionMyocytehypertrophyMyocyteinjuryIncreasedarrhythmiasDiseaseprogression1b1b1b21VascularsympatheticactivityVasoconstriction1ActivationofRASAdrenergicPathwayinHeartFailureProgressionBeta-blockerTherapyinHe

5、artFailurePotentialBeneficialEffectsProtectionfromCatecholamineToxicityReninAngiotensinSystemReversalofRemodelingUp-regulationofb-adrenergicReceptorsAncillaryFactorsMajorPlaceboControlledTrialsof-BlockadeinHeartFailure34%CumulativeMortality(%)Days20155010P=.0062(adjust

6、ed)MetoprololCR/XL(n=1990)Placebo(n=2001)USCarvedilolTrials1ProbabilityofEvent-freeSurvivalCarvedilol(n=696)Placebo(n=398)DaysP<.0010.0010020030040065%1.00.80.70.9MERIT-HF2Survival(%ofPatients)1009080607006000400300200100DaysCarvedilol(n=1156)Placebo(n=1133)50060004003

7、0020010050035%P=.00013COPERNICUS4Days0.02004008001.00.80.6P<.000134%Bisoprolol(n=1327)Placebo(n=1320)CIBIS-II30600Survival1PackerMetal.NEnglJMed.1996;334:1349–1355.2MERIT-HFStudyGroup.Lancet.1999;253:2001–2007.3CIBIS-IIInvestigators.Lancet.1999;353:9–13.4PackerMetal.NE

8、nglJMed.2001;344:1651–1658.COPERNICUS:All-CauseMortality%Survival10090806070502402016128428MonthsAllpat

当前文档最多预览五页,下载文档查看全文

此文档下载收益归作者所有

当前文档最多预览五页,下载文档查看全文
温馨提示:
1. 部分包含数学公式或PPT动画的文件,查看预览时可能会显示错乱或异常,文件下载后无此问题,请放心下载。
2. 本文档由用户上传,版权归属用户,天天文库负责整理代发布。如果您对本文档版权有争议请及时联系客服。
3. 下载前请仔细阅读文档内容,确认文档内容符合您的需求后进行下载,若出现内容与标题不符可向本站投诉处理。
4. 下载文档时可能由于网络波动等原因无法下载或下载错误,付费完成后未能成功下载的用户请联系客服处理。